Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
366 Patents
#4 in Tucson, AZ
#13 in Arizona
#1,251 in US
#2,514 in the World
Research Corporation Technologies, Inc.
Forward Citations = 7,537
408 inventors:
Tucson, AZ, United States of America
Research Corporation Technologies, Inc.
% Expired Patents = 5.7
CIPO Patents = 41
EPO Patents = 10
Trademarks = 3
Forward Citations = 7,537
Loading Chart...
Loading Chart...
408 inventors (with patents filed for the assignee):
Louis A Carpino (15 out of 26 patents)
Richard Craig (13 out of 27 patents)
Kurt R Gehlsen (12 out of 12 patents)
4. John D Buynak (11 out of 21 patents)
5. William H Pirkle (11 out of 11 patents)
6. Eric T Kool (10 out of 35 patents)
7. Shohei Koide (9 out of 25 patents)
8. David M Center (9 out of 15 patents)
9. Hardy Kornfeld (9 out of 14 patents)
10. William W Cruikshank (8 out of 17 patents)
11. Christopher J Welch (8 out of 8 patents)
12. Thomas G Chappell (7 out of 10 patents)
13. Kevin J Parker (7 out of 36 patents)
14. Arthur G Schwartz (7 out of 14 patents)
15. Robert A Magarian (7 out of 11 patents)
Core Competencies:
Protein Glycosylation
Engineered Polypeptides
Antibody-Like Polypeptides
Pichia Pastoris
Ribotoxin Molecules
Magnetic Resonance Imaging
Cancer Imaging
Gene Therapy
Peptide Synthesis
Fluorescent Nucleoside Analogs
Beta-Lactamase Inhibitors
Viable Gram-Negative Bacteria
366 patents:
10. 9976131 - Ribotoxin molecules derived from sarcin and other related fungal ribotoxins (2018-05-22),
11. 9803210 - Fusion proteins comprising immunoglobulin constant domain-derived scaffolds (2017-10-31),
Company Overview
Research Corporation Technologies, Inc., based in Tucson, AZ, specializes in the field of protein engineering, focusing on innovative solutions for biopharmaceutical applications. The company develops advanced technologies related to protein glycosylation and engineered polypeptides, enhancing therapeutic efficacy and safety. Their expertise extends to antibody-like polypeptides and ribotoxin molecules, contributing to breakthroughs in cancer imaging and gene therapy. Relying on platforms like Pichia Pastoris, RCT aims to address complex challenges in medical diagnostics and treatment.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Research Corporation Technologies, Inc.. Retrieved from https://idiyas.com/company/research-technologies
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
41 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
10 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]